{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:55:52Z","timestamp":1782460552568,"version":"3.54.5"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Respiratory syncytial virus (RSV) is the leading cause of hospitalization for bronchiolitis in infants worldwide, and age (&amp;lt;6 months) and underlying comorbidities (e.g., prematurity, congenital heart disease) are risk factors for severe disease. However, some centers face challenges in identifying and implementing preventative measures, and best practices, for the care of at-risk infants. Therefore, this study aimed to identify best practice examples in RSV care for neonatal and pediatric populations in leading centers globally, and to understand how these practices can be widely implemented. Following a literature review, multidisciplinary teams were interviewed in 10 centers globally (1 center per country; 40 interviews conducted between May and November 2023). Centers were included based on pre-determined criteria (e.g., type of center, services provided, focus on RSV research) to ensure a representative view of RSV care. The identified best practice interventions were critically reviewed by a group of RSV experts [healthcare professionals (HCPs) and a patient group representative] and assessed for their impact on patient care and transferability to other centers. Fifty-seven unique best practice interventions were identified, sixteen of which were prioritized, across five best practice themes: (1). Caregiver education and engagement: Provision of timely caregiver education on RSV infection and care. (2). HCP education: Provision of continuous evidence-based HCP education. (3). HCP-led RSV prophylaxis services: Additional support services to ensure at-risk infants are protected ahead of the RSV season. (4). Protocols and ways of working: Establishing evidence-based procedures to ensure best practices are followed within clinical practice. (5). Technology and innovation: Leveraging digital services to optimize care delivery and experience. This study identified interventions that may improve patient outcomes and quality of care for RSV disease in the pediatric and neonatal populations. The next steps will be to disseminate and implement best practice examples across healthcare systems and care settings globally.<\/jats:p>","DOI":"10.3389\/fped.2025.1590842","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:43:32Z","timestamp":1747842212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Improving the quality of care of respiratory syncytial virus in the neonatal and pediatric populations globally"],"prefix":"10.3389","volume":"13","author":[{"given":"Fungwe","family":"Jah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuncion","family":"Mejias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendai","family":"Nzirawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Travan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareena","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolga","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Al-dandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Mahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.vaccine.2020.01.020","article-title":"Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a world health organization-sponsored meeting","volume":"38","author":"Driscoll","year":"2020","journal-title":"Vaccine"},{"key":"B2","article-title":"Centers for Disease Control and Prevention, Respiratory Syncytial Virus (RSV) in Infants and Young Children","year":"2024"},{"key":"B3","article-title":"World Health Organization, Pneumonia in children","year":"2022"},{"key":"B4","article-title":"UK Government Publications, Respiratory syncytial virus (RSV): symptoms, transmission, prevention and treatment","year":"2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/00063198-200205000-00011","article-title":"Respiratory syncytial virus infection: clinical features, management, and prophylaxis","volume":"8","author":"Greenough","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"B6","article-title":"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children","author":"Barr","year":"2024"},{"key":"B7","article-title":"RSV Immunization Guidance for Infants and Young Children I RSV I CDC (accessed November, 2024)","year":"2024"},{"key":"B8","article-title":"EMA\u2014New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection (accessed November 2024)","year":"2022"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"B10","article-title":"The Indirect Impact of RSV: Survey Report","year":"2023"},{"key":"B11","article-title":"The Burden of Respiratory Syncytial Virus (RSV) in Europe: A White Paper","year":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/pediatric14020021","article-title":"Respiratory syncytial virus: knowledge, attitudes and beliefs of general practitioners from north-eastern Italy (2021)","volume":"14","author":"Ricc\u00f2","year":"2022","journal-title":"Pediatr Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2049936119865798","DOI":"10.1177\/2049936119865798","article-title":"Respiratory syncytial virus: diagnosis, prevention and management","volume":"6","author":"Barr","year":"2019","journal-title":"Ther Adv Infect Dis"},{"key":"B14","article-title":"Pharmacy Times. Survey Results Highlight Need for More Parent Education About Respiratory Syncytial Virus","author":"Antrim","year":"2023"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1080\/14760584.2022.2108799","article-title":"Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies","volume":"21","author":"Mortensen","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1186\/s12879-021-06629-z","article-title":"The impact of childhood RSV infection on children\u2019s and parents\u2019 quality of life: a prospective multicenter study in Spain","volume":"21","author":"D\u00edez-Gand\u00eda","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B17","first-page":"2","article-title":"The burden of respiratory syncytial virus: understanding impacts on the NHS, society and economy","volume":"10","author":"Fusco","year":"2022","journal-title":"Rand Health Q"},{"key":"B18","article-title":"UK Government Press Release, National RSV vaccination programme announced","year":"2024"},{"key":"B19","article-title":"Centers for Disease Control and Prevention, Respiratory Syncytial Virus (RSV) Vaccination for Pregnant People: FAQs for Healthcare Professionals","year":"2023"},{"key":"B20","doi-asserted-by":"publisher","first-page":"126041","DOI":"10.1016\/j.vaccine.2024.06.009","article-title":"Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: subset analysis from the pivotal randomized phase 3 MATISSE trial","volume":"42","author":"Otsuki","year":"2024","journal-title":"Vaccine"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1590842\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:43:33Z","timestamp":1747842213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1590842\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":20,"alternative-id":["10.3389\/fped.2025.1590842"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1590842","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"article-number":"1590842"}}